A Fourth Straight Record Year and the Highest Q4 Volume Ever, but the Stock Sits at an All-Time High Into a 2026 Cost Step-Up

Results vs. Consensus

Year-over-Year Comparison (Q4)

*GAAP net income and EPS include a one-time gain on the OSTTRA divestment; the adjusted figures exclude it.

Full-Year 2025 vs. 2024

Revenue — a record Q4, led by the commodity complex

Q4 revenue of $1.65B (+8.1% YoY) rebounded firmly from the soft Q3, with clearing and transaction fees of $1.33B (+7.8%) doing most of the work on a record Q4 ADV of 27.4M. Full-year revenue of $6.5B (+6%) set records in five of six asset classes and, alongside a record $803M market-data year (+13%), delivered the fourth consecutive record-revenue year. The composition is instructive: the Q4 volume surge was disproportionately metals (+114% YoY on the gold and silver rally) and equities (+22% on renewed volatility), while the largest book, interest rates, was flat-to-down. The franchise's diversification is doing exactly what it is supposed to: a different set of asset classes carried the quarter than carried Q2.

Margins — 69.4% for the year, but the tailwind is spent

The full-year adjusted operating margin of 69.4% (+110bp) is the payoff from a year of unusually disciplined cost growth, adjusted annual expenses ex-license of ~$1.625B, held roughly flat while revenue grew 6%. The Q4 margin of 67% is seasonally lower on higher year-end spend. The critical forward point is that this margin tailwind has largely run its course: management guided 2026 adjusted expenses ex-license up to ~$1.695B (+4.3%) to fund the new-initiative build-out (24/7 crypto, securities clearing, event contracts). The margin story shifts in 2026 from cost-cut leverage to reinvestment.

EPS — 10% growth, cleanly earned, but read the adjusted line

Adjusted diluted EPS of $2.77 grew 10% year-over-year and beat the ~$2.74 consensus; full-year adjusted EPS of $11.20 grew 9%. This is the number to anchor on. The GAAP figure of $3.24 (+35%) is inflated by the one-time OSTTRA divestment gain that runs through non-operating income and is excluded from adjusted results, so it materially overstates the underlying earnings step-up. The clean 10% adjusted growth is high-quality, operationally sourced, and supported by the volume rebound, firm RPC, and record market data, though it, too, benefited from the still-elevated float line.

Segment Performance

The quarter's segment signature is a mirror image of Q3: the volatility that drained out over the summer came roaring back in the commodity and equity complexes, while the rates book stayed quiet. Metals was the standout by a wide margin, and equities rebounded sharply, together driving the record Q4 total.

Average Daily Volume by Product Line

Rate Per Contract by Product Line

Metals — the standout, +114% on the precious-metals rally

Metals ADV more than doubled year-over-year to 1.4M (and rose 75% sequentially) as gold and silver ran to new highs and pulled in both institutional hedgers and a wave of retail Micro traders. The RPC fell to $1.295 as the Micro mix surged, but on more-than-doubled volume the fee-dollar contribution was strongly positive. Management raised silver margins to a notional regime during the quarter, and rather than triggering a sell-off, silver made a new high, evidence of a healthy, long-biased participant base. A 100-ounce silver contract launches shortly to complement the successful one-ounce gold contract (66k ADV).

Assessment: Metals is small in the mix but was the quarter's clear engine, and the dynamic, headline move in the underlying pulling retail into Micros, then cross-selling the complex, is the flywheel working. Some of this is cyclical (precious-metals rally), but the retail-product expansion (gold, now silver) is a durable structural add. A genuine bright spot.

Equity Indexes — sharp rebound, Micros at a record

Equity ADV of 7.7M jumped 22% year-over-year and 23% sequentially as volatility returned to the equity tape, and Micros hit a record 4.4M ADV (+59% in Q4). The equity RPC fell to $0.611 precisely because of that Micros surge, the mirror image of the Q3 uplift. The FTSE Russell (through 2037) and NASDAQ (through 2039) license extensions secured earlier in the year underpin the franchise.

Assessment: The rebound confirms that Q3's equity softness was a volatility lull, not a share loss, and the record Micros quarter shows the retail engine re-accelerating when markets get interesting. The RPC give-back is the expected cost of that retail growth. Net positive; the franchise is secured for the long run.

Interest Rates — still quiet, but the strategic build is underneath

Rates ADV of 13.0M slipped 1.8% year-over-year and 2.8% sequentially, the one book that did not rebound, as the rate path stayed relatively settled. RPC held at $0.486. The forward story for rates is less about Q4 volume and more about the structural build: CME Securities Clearing won SEC approval in December (launching in 2026 ahead of the Treasury clearing mandate), the FICC cross-margining program is generating record savings, and portfolio-margin efficiencies reached ~$25B/day in the rates complex.

Assessment: Rates volume is cyclically becalmed, but the moat is being reinforced structurally through clearing and cross-margining, which deepen the capital-efficiency lock-in that keeps rates business at CME. The near-term volume is unexciting; the multi-year competitive position is strengthening. No thesis change.

Energy, Agriculturals and FX — steady, with commodity RPC firm

Energy (2.5M, +10% QoQ) and agriculturals (1.8M) recovered sequentially with firm high-RPC economics, while FX (853k) remained the smallest book but stabilized, with FX Spot+ continuing to scale. The commodity books' higher RPC ($1.2–1.4) is a meaningful support to the blended $0.707.

Assessment: The commodity complex continues to prove it can grow and hold rate independently of the financial books, and the structural drivers (US energy exports, physical-supply-chain realignment) are intact. Steady contributors; FX Spot+ remains option value. No change.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Management was confident and forward-leaning, spending the bulk of the call on the 2026 growth roadmap (prediction markets, 24/7 crypto, CME Securities Clearing, tokenized collateral) rather than dwelling on the record results. The posture on prediction markets was notably disciplined and legally precise: the CEO drew hard lines around which contracts CME will and will not list and was explicit that CME will not entangle its shareholders in gaming-vs-swaps litigation. On capital and costs, the tone shifted subtly from the prior year's cost-cut narrative to a reinvestment narrative, with management framing the 2026 expense step-up as strategic rather than defensive.

1. The Record Year and a Record Fourth Quarter

"2025 marked our fifth consecutive year of record volume with average daily volume increasing 6% to 28.1 million contracts… It was also a record year for our international business… up 8% from the previous record set in 2024." — Terry Duffy, Chairman & CEO

The full year set records in revenue, adjusted operating income, adjusted net income and adjusted EPS for the fourth consecutive time, on record volume for the fifth. Q4 delivered the highest fourth-quarter volume on record and the second-highest quarterly revenue in company history. The breadth is the story: all-time records across interest rate, energy, metals, agricultural and crypto complexes, and a record international year at 8.4M ADV. Momentum carried into 2026 with new January volume records.

Assessment: An unambiguous demonstration of franchise quality, and a reassuring rebound from the soft Q3. The volume-unpredictability concern that emerged in Q3 is eased: the Q4 rebound and the record January show the demand base is intact and simply tracks volatility. The bull pillars are all confirmed. The question, as ever with CME, is not the business but the price.

2. Prediction Markets: 68 Million Contracts in Six Weeks

"Over 68 million of these event contracts have traded in the six weeks since launch, including over 7 million markets-related contracts… This initiative represents the next step in our multiyear strategy to expand our customer base." — Terry Duffy, Chairman & CEO

The event-contract (prediction market) offering launched in December across financial and commodity products, economic indicators, and sports, and traded 68M+ contracts in its first six weeks, attracting a previously untapped customer segment plus new institutional market makers. Distribution runs through the FanDuel JV (FanDuel Predict app live) and DraftKings, with the broader 130-partner network being onboarded. The CEO was careful on scope: CME will list larger, diverse political contracts (presidential, House/Senate control) but not small races; will engage entertainment/culture selectively; and, critically, will not tie shareholders up in gaming-vs-swaps litigation, listing sports-event contracts only so long as the CFTC deems them legal swaps.

Assessment: The volume is eye-catching for a six-week-old product and validates the distribution logic, but it is early and the economics remain to be proven at scale. The CEO's legal discipline, participate as a swaps market under CFTC oversight, walk away rather than litigate gaming questions, is exactly the right way to capture the upside while ring-fencing the tail risk. We credit prediction markets as real, fast-starting optionality, not yet a modeled earnings driver.

3. The Buyback Pivot: OSTTRA Proceeds to Repurchases

"Cash at the end of the quarter was approximately $4.6 billion, including $1.3 billion in remaining [OSTTRA] proceeds. Our board has approved the use of these proceeds towards share repurchases over time. We repurchased $256 million in shares during the fourth quarter and an additional $276 million in shares thus far in 2026." — Lynne Fitzpatrick, CFO

This is the genuinely new capital-allocation development. CME, historically a variable-dividend returner that used buybacks only opportunistically, is now actively repurchasing stock with the OSTTRA proceeds: $256M in Q4 and $276M more in early 2026, with the remaining ~$1.3B earmarked for repurchases over time. The variable dividend remains (declared next week, aligned with the Q1 regular dividend), and 2025 dividends totaled $3.9B (nearly $30B returned since 2012).

Assessment: The buyback is a modest incremental positive for EPS and a signal of confidence, but the timing invites scrutiny: repurchasing at an all-time-high ~$293 is not obviously value-accretive for a name already at a full multiple. It is best read as an efficient way to return the one-time OSTTRA windfall rather than a conviction call that the stock is cheap. It supports the total-return case at the margin and keeps this a Hold, but it is not a re-rating catalyst.

4. Crypto: +92%, and 24/7 Trading Arrives Next Quarter

"In the fourth quarter, average daily volume across the complex of 379,000 was up 92% and represented over $13 billion in notional value traded per day… We will begin offering 24/7 trading for our entire crypto suite next quarter." — Terry Duffy, Chairman & CEO

Crypto had a record year, with Q4 ADV of 379k (+92%) and $13B+ in daily notional. The suite is expanding (Cardano, Chainlink, and Stellar futures launch February 9, on top of the Solana and XRP additions earlier in 2025), and 24/7 trading for the entire crypto suite arrives in Q2 2026, enabling clients to hedge the continuously-trading underlying cash markets. The 24/7 build rests on the Google Cloud transformation and the tokenized-cash initiative for weekend collateralization.

Assessment: Crypto is compounding fast and 24/7 is a well-scoped, demand-led first step in the one asset class where the infrastructure already exists. Management's continued discipline, lead in crypto because the market is already continuous, wait for demand elsewhere, is sound. Real growth, still a small share of total volume; genuine option value on the 24/7 and tokenization build.

5. CME Securities Clearing and the Treasury Clearing Mandate

"In December, we received approval from the US Securities and Exchange Commission for CME Securities Clearing. We are on track to launch this new clearinghouse later this year in advance of the SEC's US treasury clearing mandate." — Terry Duffy, Chairman & CEO

CME won SEC approval for a new securities-clearing entity to serve the coming US Treasury clearing mandate, complementing its BrokerTec cash-Treasury and futures franchises and its FICC cross-margining arrangement. Management was notably measured on the near-term revenue, framing the standalone Treasury-clearing offering as a "nice to have" and pointing instead to the DTCC/FICC cross-margining relationship (record ~$1.5B savings across 18 firms, ~$25B/day in rates efficiencies) as where the value is today.

Assessment: Strategically important as a defensive-and-offensive move around the Treasury clearing mandate, it deepens CME's capital-efficiency moat in rates, its largest book. The CEO's candor that the direct offering is a "nice to have" versus the FICC cross-margining is refreshing and correct: the value is in the cross-margin pool that keeps rates business at CME, not in clearing fees per se. A long-term moat reinforcement, not a near-term earnings event.

6. Market Data: Record Year, and the AI Question

"This marks the thirty-first consecutive quarter of growth for our data business… 50% of this revenue growth coming from new user expansion… 25% from product innovation… the remaining 25% [from] pricing integrity." — Julie Winkler, Chief Commercial Officer

Market data crossed $800M for the year (a record $803M, +13%) and set a Q4 record at $208M (+15%), its 31st straight quarter of growth, with a 3.5% rack-rate increase effective January 1. Pressed on AI disintermediation risk, management argued CME's data is proprietary, golden-source input for risk management and backtesting, not the kind of surveillance/analytics data vulnerable to AI substitution, and that AI more likely enhances than disintermediates its franchise.

Assessment: Market data remains the quiet compounder inside CME, a high-margin annuity with demonstrable pricing power and a balanced growth mix (new users, innovation, price). The AI rebuttal is credible: exchange market data is a unique, non-substitutable input, not a commoditized analytics feed. This line is core non-volume ballast and a genuine positive. The one watch item is whether AI-era data-licensing terms evolve, which management says it is actively managing.

7. Pricing Strategy: Moving Away From the December Cadence

"We are going to move away from consolidating these types of transaction fee changes in the December time frame… we may do them at different times during the year versus that consolidated change in the December time frame going forward." — Lynne Fitzpatrick, CFO

CME published transaction-fee changes effective April 1 (most impactful in precious metals, Micros, crude oil, and grains), which combined with the January market-data increase and incentive revisions should add ~1–1.5% to total revenue on similar activity. Management is abandoning the long-standing December-consolidation cadence in favor of real-time, initiative-driven pricing changes through the year, on the reasoning that a growing new-product slate warrants more thoughtful, distributed timing.

Assessment: The ~1–1.5% revenue uplift is in line with prior years, so the quantum is unchanged; the process change reduces the analyst community's ability to model a clean annual pricing step, which the Street pushed back on. Net neutral on economics, mildly negative on transparency. It reflects a business running more initiatives on more timelines, which is the broader theme of the year.

8. The 2026 Expense Step-Up

"For 2026 guidance, we expect total adjusted operating expenses, excluding license fees, to be approximately $1.695 billion. This includes our typical core expense growth, as well as reinvestment related to the new initiatives ramping up this year, including 24/7 crypto trading, securities clearing, and event contracts." — Lynne Fitzpatrick, CFO

After a year of unusually low cost growth (adjusted expenses ex-license roughly flat at ~$1.625B), management guided 2026 adjusted expenses ex-license up ~4.3% to ~$1.695B, plus ~$85M of capex and a 23.5–24.5% adjusted tax rate. The step-up funds the new-initiative build-out. The Google Cloud spend (~$100M in 2025, $29M in Q4) is now folded into the overall guide as on-premise costs roll off and the two become hard to disaggregate.

Assessment: This is the reversal of the cost-cut tailwind we flagged at Q3, and it is the single most important negative in the print for the 2026 model. Reinvestment for growth is the right use of a strong balance sheet, but it means the margin can no longer expand on cost discipline alone, EPS growth in 2026 leans on revenue (volume + pricing + new products) and capital return rather than continued cost leverage. Appropriate strategically; a genuine headwind to the near-term margin trajectory.

9. Tokenized Collateral and the Efficiency Roadmap

"We have an initiative that we are rolling out with Google that will be coming out this year on tokenized cash… we are not going to put the enterprise at risk by taking something that we cannot get our arms around on a token." — Terry Duffy, Chairman & CEO

CME will roll out tokenized cash in 2026 via its Google partnership and a depository-bank relationship, and is evaluating what forms of tokenized collateral (stablecoins, tokenized deposits, tokenized money funds) to accept, with the answer depending entirely on the issuer's credit and appropriate haircuts. Management is also exploring its own coin on a decentralized network for industry use. The $80B of average daily margin savings (up ~$20B YoY) is the concrete expression of the capital-efficiency mission tokenization is meant to extend.

Assessment: The right posture, engage with tokenization as a risk-managed efficiency tool, accept only high-credit tokens with appropriate haircuts, rather than chase the trend. It positions CME on the front foot against tokenization-disruption fears and extends the capital-efficiency moat that is the core of the franchise. A 2026-and-beyond build with no near-term earnings weight but real strategic value.

10. Customer Health Through Elevated Volatility

"When we changed the margins on silver, some thought that the market would sell off… it went and made a new historic high… So I would say the customer is very healthy throughout all the different asset classes." — Terry Duffy, Chairman & CEO

Asked about customer health amid large underlying swings and repeated metals margin increases, management pointed to steady-to-rising open interest (~125M contracts), double-digit growth in the institutional base alongside retail, and volume growth across regions and in both futures and options as evidence of a healthy, risk-on ecosystem. The silver example, a margin increase that coincided with new highs rather than a sell-off, was offered as proof the participant base is robust.

Assessment: The customer-health read is genuinely reassuring: broad-based growth (institutional and retail), rising open interest, and resilience to margin changes all point to a durable demand base rather than a leverage-fueled spike. It supports the view that the record year reflects real, sticky risk-management demand. Constructive, and consistent with the open-interest signal we have tracked all year.

Guidance & Outlook

The 2026 guide marks a clear pivot from cost discipline to reinvestment: adjusted expenses ex-license step up ~4.3% to fund 24/7 crypto, CME Securities Clearing, and event contracts, capex rises to ~$85M, and the tax rate ticks up. The offsets are a ~1–1.5% revenue uplift from fee and incentive changes and the widening new-product slate. Management still declines to guide volume (per policy) and pointed to record January activity as an encouraging start.

Implied 2026 setup: With the cost tailwind spent and the float-income tailwind fading as the Fed cuts, 2026 EPS growth leans on revenue (volume, pricing, and the new-product ramp) plus the incremental buyback. Our base case is mid-single-digit revenue growth off the record 2025 base, with EPS growth similar or slightly lower as reinvestment compresses the margin, unless a volatility regime lifts volumes above the run-rate. The new initiatives are optionality on top, not yet base-case contributors.

Guidance style: Consistent, guide the controllable, decline to forecast volume, but the substance shifted this year from "we are holding costs" to "we are investing for growth." That is a defensible use of a strong balance sheet, but it changes the earnings-quality narrative: the easy margin expansion is behind, and the next leg depends on the new products actually monetizing.

Analyst Q&A Highlights

Customer Health Amid Elevated Volatility and Margin Increases

The opening question probed how the customer base is holding up through large underlying swings and repeated metals margin increases. Management pointed to steady open interest, broad-based growth, and the silver episode as evidence of a healthy, risk-on ecosystem.

Q: "Just given some of the volatility, you guys have raised margin requirements… in the metals complex a few times. We have seen really large swings in the underlying. So hoping just to get a little bit more context around how you think the customer base is performing through these kind of elevated periods of volatility."
— Dan Fannon, Jefferies

A: "When we changed the margins on silver, some thought that the market would sell off… That did not affect the customer base or the product at all because it went and made a new historic high… the customer is very healthy throughout all the different asset classes." (Duffy) … "Our institutional base is growing double digits right now… Open interest is steady to increasing… these are indicators of a risk-on environment." (Sammann)
— Terry Duffy, Chairman & CEO; Derek Sammann, Global Head of Commodities

Assessment: A reassuring, specific answer: broad-based (institutional plus retail) growth and rising open interest through a high-volatility, rising-margin window point to a durable demand base rather than a fragile, leverage-driven spike. The silver example is a clean illustration that the participant base is robust to friction. It supports reading the record year as sticky risk-management demand, and it directly addresses the volume-durability concern that surfaced in Q3.

Engagement and the Regulatory Landscape for Prediction Markets

A question sought detail on early engagement and inbounds in the prediction-market space and the CEO's read on the CFTC's recent posture. Management described new institutional and market-maker interest and drew a firm line on the legal strategy.

Q: "I was hoping you could talk about what you have seen to date in terms of engagement and inbounds from market makers and institutions looking at the prediction market space… And… your updated thoughts just on the legal and regulatory landscape around prediction markets and some of the comments… from the CFTC recently."
— Patrick Moley, Piper Sandler

A: "The last thing I am going to have CME Group do is get tied up in a bunch of legal battles and court over sports… I believe that the CFTC looks at these contracts as swaps… he is committed to overseeing this product… we are not going to get bogged down in a bunch of litigation over whether this is sports gambling or swaps markets. Today, they are called swaps markets, which we participate in."
— Terry Duffy, Chairman & CEO

Assessment: The strategy is exactly right: capture the distribution upside of event contracts as a CFTC-regulated swaps market, while refusing to entangle shareholders in the gaming-vs-swaps litigation swirling around the states and tribes. It ring-fences the tail risk without foreclosing the opportunity, and the new institutional/market-maker inbounds suggest the product is pulling fresh liquidity into CME. The upside is real and fast-starting; the discipline on legal exposure is what makes it investable rather than a headline risk.

The Change to the Fee-Increase Cadence

An analyst pushed back on CME abandoning its predictable December fee-change cadence, noting it had provided useful transparency into the long-term revenue growth rate. The CEO defended running pricing on a real-time basis.

Q: "We are all programmed to look for an announcement in Q4 and see the changes in Q1. But going forward, it looks like we are not going to get that same from the CME. So curious what drove the change, and does this mean that increases will be smaller in the future? Because I thought the old method worked pretty well, and it provided transparency."
— Craig Siegenthaler, Bank of America

A: "We think that we need to do pricing changes as we continue to deliver value, and we do not necessarily need to do that in December every year… Some increases may be smaller. Some increases may be larger. Some may not be there at all… we are running this business on a real-time basis."
— Terry Duffy, Chairman & CEO

Assessment: The economic quantum is unchanged (~1–1.5% revenue uplift, in line with prior years), so this is a transparency question, not an earnings question. Distributing fee changes through the year reduces the Street's ability to model a clean annual pricing step, which is a modest negative for forecastability, but it reflects a business genuinely running more initiatives on more timelines. Neutral on value, mildly negative on modeling convenience.

Capital Return and Market-Data Durability Against AI

A two-part question asked about the go-forward buyback approach relative to the OSTTRA proceeds and about the durability of market-data revenue against AI disintermediation risk. Management confirmed the buyback intent and made a specific case for data's resilience.

Q: "It is great to see you buy back some stock… How do we think about maybe the prospective approach to capital?… And… could you speak to the durability of [market data] given what seems to be a very frenetic change in the expectation around subscription and data packages given AI disintermediation risk?"
— Bill Katz, TD Cowen

A: "We will be using the [OSTTRA] proceeds towards repurchases… we will continue to be deploying that capital towards repurchases over time." (Fitzpatrick) … "This is proprietary data that people need for risk management… I actually believe we are in a situation where AI could enhance our business going forward, not disintermediate or disrupt it." (Duffy)
— Lynne Fitzpatrick, CFO; Terry Duffy, Chairman & CEO

Assessment: Two useful confirmations. On capital, the OSTTRA windfall is going to buybacks over time, an efficient return of a one-time gain, though repurchasing at all-time highs is not obviously value-accretive. On data, the AI rebuttal is credible: exchange market data is a unique, golden-source input for risk management and backtesting, not a substitutable analytics feed, so the disintermediation risk that hangs over some data peers is genuinely lower for CME. Both support the total-return case that underpins the Hold.

Google Cloud Migration Progress and 2026 Cost

An analyst asked for an update on the Google Cloud migration and the associated 2026 expense. Management reported the migration on plan and folded the cloud cost into the overall guide.

Q: "I just wanted to ask a question on the progress on the Google Cloud migration and if you can quantify the expense in the fourth quarter and expected for 2026."
— Ashish Sabadra, RBC Capital Markets

A: "In the fourth quarter, we had about $29 million in spending related to the cloud environment… our total for the year was right around $100 million… It is getting harder and harder… to disaggregate the Google-related charges and our base charges because we have seen so many of the on-premises expenses start to roll off… that expense is built into our overall guidance." (Fitzpatrick) … "We will be making that available to clients for testing in 2027." (Cutinho, on the ultra-low-latency Chicago region)
— Lynne Fitzpatrick, CFO; Sunil Cutinho, Chief Information Officer

Assessment: The migration flipping from a discrete, worrisome line to something folded into base tech spend is a sign of maturity: the on-premise-to-cloud transition is largely de-risked, and the ultra-low-latency piece (the hardest part) has a credible 2027 client-testing timeline. It removes a multi-year overhang, though it also removes the visibility that let investors track cloud savings. Net positive on execution; the cost is now embedded in the stepped-up 2026 guide.

Cross-Margining and Treasury Clearing Effects on Collateral

The final question asked what cross-margining programs are launching and how Treasury/repo clearing might affect collateral balances over time. Management detailed the FICC program and downplayed the standalone Treasury-clearing revenue in favor of the cross-margin value.

Q: "You also got approval to launch treasury and repo clearing. How would you expect these two initiatives to impact collateral balances over time?"
— Ken Worthington, JPMorgan

A: "The CME FICC cross-margining program for clients… has been running since 2024. We have 18 firms participating. We generated record savings for those firms of about $1.5 billion… we are generating about $25 billion in the interest rate complex." (Cutinho) … "Our treasury clearing offering is a nice to have… the true value that we see right now and today is what DTCC and the FICC Clearing Organization [provide]." (Duffy)
— Sunil Cutinho, CIO; Terry Duffy, Chairman & CEO

Assessment: The CEO's candor is the signal: the direct Treasury-clearing offering is a "nice to have," while the real value is the FICC cross-margining relationship that generates ~$25B/day of rates efficiencies and keeps rates business at CME. This reframes the Treasury-clearing initiative correctly, as moat reinforcement (capital efficiency, client lock-in) rather than a new fee stream. It is a multi-year strategic positive for the rates franchise, not a 2026 revenue catalyst.

What They're NOT Saying

1. Prediction-market economics still undisclosed: 68M contracts in six weeks is a striking volume figure, but management gave no revenue, RPC, or margin detail. The distribution logic is clear; the monetization is a black box, so the fast-start volume cannot yet be translated into earnings.
2. The float tailwind's 2026 fade is under-quantified: The non-operating line remained a sizeable earnings contributor on elevated balances, but management did not frame how much rate cuts subtract in 2026, a line that has quietly supported EPS all year.
3. Buying back stock at the highs: Management presented the buyback as returning the OSTTRA proceeds but did not address the valuation of repurchasing at an all-time high, leaving open whether this is value-accretive or simply an efficient return of a windfall.
4. 2026 EPS growth not framed: With costs stepping up ~4.3% and the float tailwind fading, management guided expenses precisely but gave no revenue or EPS framework, leaving the net earnings-growth trajectory for 2026 conspicuously open.
5. Treasury-clearing revenue quantification: Calling the offering a "nice to have" is candid, but it also means management is signaling not to expect meaningful near-term clearing revenue from a heavily-promoted strategic initiative.

Market Reaction

• Pre-print setup: CME closed at $293.07 on February 3, entering the print at the very top of its 52-week closing range ($236.52–$293.07), i.e. near an all-time high, up 20.8% over the trailing twelve months and up 6.5% in just the prior 30 days. The stock had rallied ~9% off the ~$268 Q3-print level, fully reversing the earlier de-rating.
• Reaction session (February 4, before-open report): The stock opened roughly flat ($292.40), traded a $286.53–$296.76 range, and closed at $294.62, up 0.5% (+$1.55) on elevated 3.2M shares (1.7x the 30-day average). The S&P 500 fell 0.5% the same day, so CME outperformed the tape by ~1 point.

A record fourth quarter and a fourth consecutive record year, greeted with a 0.5% pop, is the same signature we have seen all year on this name: at an all-time high, the bar is set at perfection, so even excellent results clear it only narrowly. The elevated volume (1.7x) shows genuine engagement with the print, but the muted price move says the good news, record volumes, a fast-starting prediction-market business, the buyback pivot, was already substantially in the stock.

The setup is the least attractive of the four quarters we have covered: the stock has round-tripped from the Q3 pullback back to the highs, the 2026 cost guide steps up, and the float tailwind that padded 2025 fades. None of that is bearish, the franchise is performing, but paying an all-time-high multiple into a reinvestment year with a fading below-the-line tailwind is precisely the setup in which patience is rewarded.

Street Perspective

Debate: Do the New Growth Engines Justify Paying Up at the Highs?

Bull view: Prediction markets (68M contracts in six weeks), 24/7 crypto, and Treasury clearing represent a genuine step-change in the growth surface, layered on CME's scale, that warrants a premium and a higher forward growth rate than the market is crediting.

Bear view: Each initiative is early and unquantified, the 2026 cost step-up funds them before they earn, and at an all-time-high multiple the stock already prices continued success; the risk is paying full value for optionality that takes years to monetize.

Our take: The optionality is real and unusually rich this quarter, but it is a multi-year story funded by a near-term margin headwind. At an all-time high, you are paying for the optionality up front. We would rather own the optionality on a pullback than at the highs, which keeps us at Hold.

Debate: Is the Buyback Pivot a Positive Signal or a Valuation Red Flag?

Bull view: Directing the OSTTRA proceeds to repurchases is a shareholder-friendly, EPS-accretive use of a windfall and a signal of management's confidence in the franchise's durability.

Bear view: Repurchasing at an all-time-high ~$293, for a company that historically returns cash via variable dividend, is buying high; it is an efficient windfall return, not evidence the stock is cheap.

Our take: Closer to the bears on the valuation point but not alarmed: this is best read as an efficient, tax-aware return of a one-time gain rather than a conviction call on the stock's cheapness. It is a marginal EPS positive and a total-return support, not a re-rating catalyst.

Debate: Can 2026 EPS Grow Against a Cost Step-Up and a Fading Float Tailwind?

Bull view: Fee increases (+1–1.5%), record January volumes, the new-product ramp, and the buyback can more than offset the ~4.3% cost step-up and the float fade, sustaining high-single-digit EPS growth.

Bear view: With the cost tailwind spent and rate cuts pressuring the ~$200M/quarter non-operating line, EPS growth could stall to low single digits unless a volatility regime lifts volumes above the run-rate.

Our take: The honest answer is that 2026 EPS growth is more volume-dependent than it has been in years, because the two reliable non-volume supports (cost cuts, float income) are both reversing. That raises the range of outcomes and, at a full multiple, argues for the discipline of a Hold until either the multiple resets or the new products demonstrably monetize.

Model Update Needed

Valuation impact: The 2026 cost step-up and fading float tailwind roughly offset the fee uplift, buyback, and volume rebound, leaving EPS growth more volume-dependent than usual. At an all-time-high ~$293 (~26x trailing / ~24–25x forward), fair value is at or slightly below the current price on a 12-month view, consistent with a Hold. The record quarter does not change the constraint: the price already reflects the quality plus a healthy dose of the optionality.

Thesis Scorecard Post-Earnings

Overall: Unchanged, with the balance of risks shifting from volume to valuation and margin. The volume-durability concern (Bear-2) eased as Q4 rebounded to a record and January set new records, but the two below-the-operating-line supports that flattered 2025, cost discipline and float income, both reverse in 2026 (Bear-3 escalates to EMERGING), and the stock's round-trip back to an all-time high re-elevates the valuation constraint (Bear-1). All four bull pillars remain confirmed.

Action: Maintain Hold. A superb record year from a wide-moat franchise, but the stock is back at an all-time high into a reinvestment year with a fading float tailwind, the least attractive risk/reward of the four quarters we have covered. The buyback pivot and record momentum keep it a Hold rather than lower. We upgrade on a meaningful pullback that resets the multiple, or on evidence the new-product slate is monetizing into hard numbers.